PepsiCo faces fresh scrutiny to show its plan can generate sustainable growth as consumers change their consumption patterns and seek healthier food and drink. PepsiCo, which owns brands such as Pepsi, Lay’s, Doritos, Gatorade, and Mountain Dew, has launched a cost-cutting drive, new products and pricing initiatives in response. But investors want to see more concrete signs that these efforts will lift it for the long term.
Pressure comes after almost $4 billion investment by activist investor Elliott Investment Management in 2025. Following talks with Elliott, PepsiCo revealed a plan to speed up revenue growth, improve operating margins, raise affordability and lower costs. Part of the plan involved a revamp of the company’s manufacturing, distribution, and product portfolio.
It hit home in the company’s 3rd-quarter earnings statement, published Oct. 8, 2026. Net revenue at PepsiCo was roughly $25.27 billion, a 5.6% rise from the year prior. Organic revenue, which considers pricing and volume, was 3.1%, indicating gross revenue from the product. Core operating profit was only 3% higher, and the core operating margin fell from 17.3% a year ago to 16.9% as sales grew. This shows the divergence between sales growth and underlying profitability.
North America remains a key part of the story in the turnaround. Inflation-sensitive consumers, competition, and some weaker demand for certain legacy foods have made the region a challenge for PepsiCo. The company has been rolling out lower prices on some leading brands, with initial discounts of as much as 15% on some Lay’s and Doritos items designed to make the products more attractive to shoppers and prompt them to buy more often. It has also brought in new products and stepped up advertising spend, but investors remain skeptical whether the investments will pay off.
Dietary shifts present yet another challenge. Customers are seeking foods with nutrition value, such as added protein, fiber, and ingredients that are less processed. The increased popularity of GLP-1 weight-loss drugs has gained attention because they help curb appetite and limit food consumption for some people, which might shift the demand for snacks and sugary drinks. It remains to be seen how it will impact Pepsi’s sales, but it has prompted food companies to revisit their product mix.
That is the direction PepsiCo is already heading with launches like Doritos Protein and SunChips Fiber and efforts to simplify ingredients across some of its brands. The company is also making investments in hydration-oriented beverages and those with functional benefits. Its purchase of Poppi and its existing Alani and Celsius businesses beef up its presence in the prebiotic soda segment and energy drinks respectively for potential growth outside traditional soft drinks.
The drinks business is still problematic but. PepsiCo revealed a 5 per cent revenue growth from North American drinks during its third quarter, though the uplift was principally driven by acquisitions rather than improving consumer appetite. Beverage volumes fell 2 per cent in the quarter. CEO Ramon Laguarta has said the company plans to take a heavier focus on soft-drinks performance through further advertising, innovation, and execution with bottlers.
